| Member | Buys | Sells | Est. net | Last move |
|---|---|---|---|---|
| Gilbert Cisneros CA31 | 2 | 1 | +$8.0K | Bought Apr 14, 26 |
| Rob Bresnahan PA08 | 1 | 1 | +$0 | Sold May 15, 25 |
| Ritchie John Torres NY15 | 1 | +$8.0K | Bought Sep 26, 24 |
| Traded | Member | Owner | Type | Amount | Filed | Report |
|---|---|---|---|---|---|---|
| Apr 14, 26 | Gilbert Cisneros CA31 | Self | Buy | $1,001 - $15,000 | May 8, 26 (24d) | |
| Dec 19, 25 | Gilbert Cisneros CA31 | Self | Sell | $1,001 - $15,000 | Jan 12, 26 (24d) | |
| Nov 18, 25 | Gilbert Cisneros CA31 | Self | Buy | $1,001 - $15,000 | Dec 15, 25 (27d) | |
| May 15, 25 | Rob Bresnahan PA08 | Self | Sell | $1,001 - $15,000 | Jun 9, 25 (25d) | |
| Feb 25, 25 | Rob Bresnahan PA08 | Self | Buy | $1,001 - $15,000 | Mar 27, 25 (30d) | |
| Sep 26, 24 | Ritchie John Torres NY15 | Self | Buy | $1,001 - $15,000 | Aug 20, 25 (328d) |
From the House's STOCK Act reports (Senate not included). Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 10, 2026 | Fukuzaki-Carlson KristinaOfficer | Sale at price 50.51 per share. | 16.8K | $849.07K |
| Sep 10, 2026 | Marcus Joel SOfficer and Director | Purchase at price 49.68 per share. | 5K | $248.40K |
| Aug 30, 2026 | Gavinet AndresOfficer | Sale at price 50.93 per share. | 10K | $509.30K |
| Aug 16, 2026 | Marcus Joel SOfficer and Director | Purchase at price 46.28 per share. | 5K | $231.40K |
| Jul 14, 2026 | Mcgrath Sheila K.Director | Stock Award(Grant) at price 0.00 per share. | 128 | — |
| Jul 14, 2026 | Cain James PDirector | Stock Award(Grant) at price 0.00 per share. | 144 | — |
| Jul 14, 2026 | Woronoff Michael ADirector | Stock Award(Grant) at price 0.00 per share. | 415 | — |
| Jul 14, 2026 | Hash SteveDirector | Stock Award(Grant) at price 0.00 per share. | 340 | — |
| Jul 14, 2026 | Klein Richard HunterDirector | Stock Award(Grant) at price 0.00 per share. | 111 | — |
| Jun 29, 2026 | Woronoff Michael ADirector | Stock Award(Grant) at price 0.00 per share. | 804 | — |
| Jun 8, 2026 | Binda Marc E.Chief Financial Officer | Sale at price 54.00 per share. | 2K | $108.00K |
| May 5, 2026 | Marcus Joel SOfficer and Director | Purchase at price 45.99 - 46.74 per share. | 7.5K | $347.56K |
| May 4, 2026 | Marcus Joel SOfficer and Director | Purchase at price 41.89 - 43.70 per share. | 7.5K | $320.42K |
| May 3, 2026 | Marcus Joel SOfficer and Director | Purchase at price 41.02 per share. | 10K | $410.20K |
| Apr 29, 2026 | Thomas Gregory CalvinChief Technology Officer | Purchase at price 41.00 per share. | 3.5K | $143.50K |
| Apr 16, 2026 | Kuhn Hallie E.Officer | Sale at price 48.20 per share. | 536 | $25.84K |
| Apr 14, 2026 | Mcgrath Sheila K.Director | Stock Award(Grant) at price 0.00 per share. | 129 | — |
| Apr 14, 2026 | Cain James PDirector | Stock Award(Grant) at price 0.00 per share. | 145 | — |
| Apr 14, 2026 | Woronoff Michael ADirector | Stock Award(Grant) at price 0.00 per share. | 407 | — |
| Apr 14, 2026 | Hash SteveDirector | Stock Award(Grant) at price 0.00 per share. | 343 | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 11.6 | -1.1 | -14.1 | -12.7 | 22.6 | 6.4 | -2.6 | -0.3 | -7.5 | -7.0 | −9.8% | ||
| 2025 | -0.2 | 5.0 | -9.5 | -21.5 | -3.4 | 3.5 | 5.2 | 7.9 | 1.1 | -30.1 | -7.8 | -8.8 | −49.8% |
| 2024 | -4.6 | 3.2 | 3.4 | -10.1 | 2.7 | -1.7 | 0.3 | 1.9 | -0.7 | -6.1 | -1.2 | -11.5 | −23.0% |
| 2023 | 10.3 | -6.8 | -16.2 | -1.1 | -8.6 | 0.0 | 10.7 | -7.4 | -14.0 | -7.0 | 17.5 | 15.9 | −13.0% |
| 2022 | -12.6 | -2.8 | 6.3 | -9.5 | -8.9 | -12.6 | 14.3 | -7.5 | -8.6 | 3.6 | 7.1 | -6.4 | −34.7% |
| 2021 | -6.2 | -4.4 | 2.9 | 10.2 | -1.6 | 2.1 | 10.7 | 2.5 | -7.4 | 6.8 | -2.0 | 11.4 | +25.1% |
| 2020 | 1.0 | -6.9 | -9.8 | 14.6 | -2.1 | 5.5 | 9.4 | -5.2 | -5.0 | -5.3 | 8.1 | 8.8 | +10.3% |
| 2019 | 14.3 | 3.2 | 4.9 | -0.1 | 2.8 | -3.6 | 3.7 | 2.4 | 2.8 | 3.1 | 2.4 | -0.6 | +40.2% |
| 2018 | -0.7 | -6.5 | 3.0 | -0.3 | 0.3 | 1.0 | 1.0 | 0.7 | -2.0 | -2.8 | 1.9 | -7.4 | −11.8% |
| 2017 | -0.3 | 7.7 | -7.4 | 1.8 | 3.7 | 3.2 | 0.6 | 0.0 | -1.9 | 4.2 | 2.5 | 2.8 | +17.5% |
| 2016 | -12.4 | -0.0 | 14.8 | 2.3 | 4.2 | 6.8 | 8.5 | -2.0 | -1.2 | -0.9 | 1.7 | 1.4 | +23.0% |
| 2015 | 9.9 | -1.7 | 2.2 | -5.8 | 0.4 | -5.7 | 6.0 | -7.2 | -1.5 | 6.0 | 2.6 | -1.9 | +1.8% |
| 2014 | 10.2 | 3.3 | 0.2 | 1.7 | 3.1 | 2.0 | 1.2 | 0.6 | -6.7 | 12.5 | 3.5 | 3.3 | +39.5% |
| 2013 | 4.6 | -1.9 | -0.2 | 2.5 | -5.9 | -4.1 | 4.2 | -10.0 | 3.5 | 3.0 | -3.8 | 0.6 | −8.2% |
| 2012 | 5.0 | -1.0 | 2.0 | 2.4 | -8.6 | 6.2 | 1.0 | 0.6 | -0.5 | -4.2 | -3.6 | 2.1 | +0.5% |
| 2011 | 5.2 | 4.1 | -2.8 | 5.4 | 0.5 | -6.2 | 5.9 | -11.2 | -15.7 | 7.7 | -0.8 | 5.2 | −5.9% |
| 2010 | -7.1 | 3.2 | 9.7 | 4.7 | -7.4 | -3.4 | 11.3 | -1.7 | 0.9 | 5.0 | -9.2 | 9.8 | +14.0% |
| 2009 | -1.7 | -32.7 | -8.9 | 0.2 | -1.6 | -0.3 | 6.5 | 46.2 | -2.4 | -0.3 | 4.1 | 14.1 | +6.5% |
| 2008 | -3.5 | -6.4 | 1.0 | 13.3 | -0.7 | -6.7 | 6.1 | 4.3 | 4.4 | -38.2 | -36.3 | 36.3 | −40.7% |
| 2007 | 7.9 | -2.9 | -4.6 | 5.5 | -0.6 | -8.0 | -11.0 | 8.4 | 3.1 | 7.1 | -4.8 | 3.5 | +1.3% |
Alexandria Real Estate Equities, Inc., an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus ecosystems in AAA life science and advanced technology innovation cluster locations, including Greater Boston, San Diego, the San Francisco Bay Area, Seattle, Maryland, Research Triangle, and New York City. Alexandria Real Estate Equities, Inc. was established in 1994 and was incorporated in Maryland.
Buy / hold / sell counts